JBM (Healthcare) Limited is an investment holding company engaged in the development, manufacture, sourcing, distribution, and marketing of branded healthcare products. It operates through three main segments: Branded Medicines, which focuses on medicines with chemical compounds as active ingredients; Proprietary Chinese Medicines, specializing in registered Chinese medicines made from herbal, animal, or mineral origins as defined in the Chinese Medicine Ordinance; and Health and Wellness Products, offering supplements, medical consumables, and non-pharmaceutical items for consumer health. The company manages a portfolio of well-known brands, including its own household names like Baoji Pills, Ho Ji Gong, Feiying Eagle Oil, Tianxitang Tianxi Pills, and Tang Taizong Huoluo Oil, alongside third-party international brands from regions such as the US, Taiwan, Germany, Ireland, and Norway. JBM (Healthcare) Limited maintains an extensive sales and distribution network across Hong Kong, Greater China, Southeast Asia, and select markets in Europe, North America, and the Caribbean, serving retailers, pharmacies, clinics, hospitals, corporate clients, and consumers via online platforms and traditional Chinese medicine practitioners. Founded in 2020 and headquartered in Kwun Tong, Kowloon, Hong Kong, it emphasizes quality control with GMP-certified manufacturing and a pharmaceutical-oriented culture to support self-care solutions in the healthcare sector.
Markedsdata leveret af TwelveData og Morningstar